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http://dx.doi.org/10.1016/j.pedneo.2Background: Birth size can affect neonatal morbidity and mortality. The insulin-like growth
factor (IGF) system is the most important endocrine factor influencing fetal growth. In the cir-
culation, IGFs (mostly IGF-I) are bound to IGF-binding protein 3 (IGFBP-3) and an acid-labile
subunit (ALS) to form a ternary complex. The ALS protects IGFs from decay and facilitates their
endocrine activity. However, the function of ALS in fetal growth has not yet been fully deter-
mined.
Methods: Venous umbilical plasma samples were obtained from 98 term neonates and
analyzed using enzyme-linked immunosorbent assays. The ALS, IGF-I, and IGFBP-3 umbilical
cord plasma levels were analyzed for their association with anthropometric measurements
of the neonates.
Results: The ALS, IGF-I, and IGFBP-3 cord plasma levels were positively correlated with birth
weight (r Z 0.42, p < 0.001; r Z 0.43, p < 0.001; and r Z 0.27, p < 0.01, respectively) and
placental weight (r Z 0.37, p < 0.001; r Z 0.31, p < 0.01; and r Z 0.30, p < 0.01, respec-
tively). In addition, the ALS cord plasma levels were also positively correlated with head
circumference (r Z 0.29, p < 0.01). Multiple linear regression analyses showed that both
ALS and IGF-I cord plasma levels were independent predictive variables for birth weighteonatology, Department of Pediatrics, Chi Mei Medical Center, 901 Zhonghua Road, Yongkang District,
et.net (W.-H. Tsai).
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140 Y.-M. Tseng et al(p < 0.01 and p < 0.005, respectively). The ALS cord plasma levels were the only independent
predictive variables, however, for head circumference and placental weight (p < 0.01 and
p < 0.05, respectively).
Conclusion: The ALS umbilical cord plasma levels are one important factor, in addition to IGF-I,
in the IGF system for predicting birth anthropometry, at least for near-term gestation. Our re-
sults suggest that the influence of ALS on the IGF system may develop prior to birth and affect
fetal growth.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Birth size can affect neonatal morbidity and mortality.
Large-for-gestational age neonates have a higher risk of
perinatal asphyxia and birth trauma, such as clavicular
fracture and brachial plexus injury.1 Small-for-gestational
age infants also have a higher risk of hypoglycemia, poly-
cythemia, asphyxia, and abnormal neurologic symptoms in
the neonatal period as well as a higher risk of long-term
developmental abnormalities.2 Moreover, birth size is
even suggested to be associated with long-term adult
problems, such as the amount of food intake, cardiovas-
cular disease, and type 2 diabetes mellitus.3,4
The insulin-like growth factor (IGF) system is the most
important endocrine factor influencing fetal growth.5 In
IGF-I or IGF-II knockout mice, the birth weights were
around 60% of those of their wild-type littermates.6 In
humans, the IGF-I gene homozygous partial deletion caused
severe intrauterine growth retardation and mutation in the
promoter region of the IGF-I gene, which led to low IGF-I
levels and low birth weight.7,8 Studies on umbilical cord
blood have also reported that IGF-I, but not IGF-II or IGF-
binding protein 3 (IGFBP-3), levels are positive predictors
of birth size.9,10
In the circulation, most of the IGF-I is bound to IGFBPs,
mostly IGFBP-3, to form a binary complex, and an 85-kDa
acid-labile subunit (ALS) to form a 150-kDa IGF-IeIGFBP-
3eALS ternary complex.11 The ALS is important for stabi-
lizing the ternary complex in the circulation.12 It protects
IGFs from decay and facilitates their endocrine activity.
Free IGF-I has a half-life of 10e12 minutes, which is
extended to 12e15 hours when forming a ternary
complex.13
In a mouse model with an inactivated ALS gene (Igfals),
mice with two null alleles (ALS/) were significantly ligh-
ter than wild-type mice by 3 weeks after birth and were
13e20% lighter by 9e10 weeks after birth.14,15 Mice with a
single null allele (ALSþ/) were only 4% lighter than wild-
type mice by 10 weeks after birth. However, in both the
ALS/ and ALSþ/ mice, birth weights were not signifi-
cantly different from the wild type. In humans, postnatal
short stature or growth failure has been reported with ALS
gene mutations.16,17 However, it is usually believed that
ALS is not important for regulating fetal growth because
birth weight and length are normal in most of the reported
patients with an ALS gene mutation.18,19
In fetal circulation, ALS umbilical cord blood levels in-
crease significantly after 25e30 weeks of gestation.20Previously, only one study, on a group of 81 preterm and
term neonates, reported that ALS umbilical cord blood
levels are one positive predictor of birth length.21 To
further explore the function of ALS in fetal growth, we
measured components of the IGF-IeIGFBP-3eALS ternary
complex in umbilical cord plasma levels of term neonates
to investigate their associations with birth anthropometry.
2. Materials and Methods
2.1. Newborns and plasma samples
Ninety-eight venous umbilical cord plasma samples (45
male; 53 female) were obtained from term newborns at the
Chi Mei Hospital (Tainan, Taiwan) between July 2005 and
January 2006. Newborns with major congenital anomalies,
multiple gestation, congenital heart diseases, suspected
congenital infection, and renal diseases were excluded
from the study. The sample was collected using a Vacu-
tainer tube (Becton Dickinson, Franklin Lakes, NJ, USA)
containing disodium ethylenediaminetetraacetic acid and
stored at 4C immediately after the newborn had been
delivered. Within 24 hours, all samples were centrifuged at
2500g for 15 minutes to obtain umbilical cord plasma,
which was stored at 80C until further analysis. The
clinical records of the neonates were reviewed to obtain
information about their gestational age, birth weight, birth
length, head circumference, and sex. Their Ponderal index
was calculated as 100 times birth weight in gram divided by
the cube of birth length in centimeter. Gestational age at
birth was calculated from the 1st day of the last menstrual
period of the mother. The placental weights were obtained
from information recorded by the Obstetrics Department.
Term neonates were defined as having 37 or more weeks of
gestation. Ethical approval was obtained from the Institu-
tional Review Board of the Chi Mei Hospital. Consent forms
were signed by the participating mothers.
2.2. Assays
The levels of IGF-I, IGFBP-3, and ALS were measured using
enzyme-linked immunosorbent assays (Diagnostic Systems
Laboratories, Webster, TX, USA). All samples were run in
triplicate. The detection limits of the assays for IGF-I,
IGFBP-3, and ALS were 0.01 ng/mL, 0.04 ng/mL, and
0.07 mg/mL, respectively. The intra-assay coefficients of
variation (CV) for IGF-I, IGFBP-3, and ALS were less than 9%,
Acid-labile subunit and birth size 14110%, and 8%, respectively. The interassay CVs for IGF-I,
IGFBP-3, and ALS were less than 7%, 12%, and 9%,
respectively.
2.3. Statistics
All data were statistically analyzed using SPSS 17.0 for
Windows (SPSS Inc., Chicago, IL, USA). Pearson correlations
were used to examine the associations between umbilical
plasma levels of the study hormones and birth weights,
birth lengths, head circumferences, and the Ponderal index
of the newborns and placental weights of the mothers.
Multiple linear regressions were used to examine the effect
of the hormone of interest on these anthropometric data of
the newborns. Significance was set at p < 0.05.
4. Results
The anthropometric data, placental weights, and cord
plasma hormone levels of the participating newborns are
provided in Tables 1 and 2. There were no significant sex
differences in umbilical cord plasma levels of the study
hormones. The weights of the neonates participated in this
study were plotted on the nationwide singleton birth-
weight percentile curves for Taiwan (Figure 1).22
4.1. Correlations between anthropometric data
and study hormones of the newborns
To explore the relationship between ALS, IGF-I, and IGFBP-
3 cord plasma levels and birth anthropometry, correlation
coefficients (r) were calculated (Table 3). The birth weight,
birth length, and head circumference were all highly posi-
tively correlated with one another. The placental weights
were positively correlated with the birth weights and birth
lengths. Moreover, the birth weights were positively
correlated with ALS, IGF-I, and IGFBP-3 cord plasma levels
(r Z 0.42, p < 0.001; r Z 0.43, p < 0.001; r Z 0.27,
p < 0.01, respectively). The relationships between birth
heights and ALS, IGF-I, and IGFBP-3 cord plasma levels were
not significant; however, the correlation coefficient be-
tween ALS and birth heights was marginally significant 0.19
(p Z 0.069). The head circumferences of the newborns
were positively correlated with ALS cord plasma levels
(r Z 0.29, p < 0.01), but not correlated with IGF-I and
IGFBP-3 levels. The Ponderal index was positively corre-
lated with ALS and IGF-I cord plasma levels (r Z 0.23,
p < 0.05 and r Z 0.25, p < 0.05, respectively). PlacentalTable 1 Anthropometry of the newborns and their placental w
All births (n Z 98)
Gestational age (wk) 39.5 (37.1e41.4)
Birth weight (g) 3160 (2300e4038)
Birth length (cm) 50.7 (45.0e58.0)
Head circumference (cm) 33.8 (31.0e36.0)
Ponderal index (g/cm3) 2.44 (1.95e3.80)
Placental weight (g) 666 (450e1100)
Data are presented as means with range in parentheses.weights were positively correlated with ALS, IGF-I, and
IGFBP-3 cord plasma levels (rZ 0.37, p < 0.001; rZ 0.31,
p < 0.01; and r Z 0.30, p < 0.01, respectively).
4.2. Predictors of birth weight, birth length, head
circumference, and placental weight
Results of multiple linear regression analyses using birth
anthropometry and placental weights as dependent vari-
able are provided in Table 4. Both ALS and IGF-I cord plasma
levels were independent predictive variables for birth
weights (p < 0.01 and p < 0.005, respectively), which
together explained 24.3% of the variance in birth weight. In
addition, ALS cord plasma levels were the only independent
predictive variables for the head circumferences and
placental weights (p < 0.01 and p < 0.05, respectively),
explaining 6.2% and 14.6% of the variance, respectively.
None of the levels of the study hormones were independent
predictive variables for birth length or the Ponderal index.
5. Discussion
We found positive associations between the components of
the IGF ternary complex in cord plasma levels and birth
anthropometry in a group of singleton Taiwanese infants
born at full term. Regression analyses indicated that both
ALS and IGF-I cord plasma levels were independent pre-
dictors for birth weight, and that the ALS cord plasma level
was also an independent predictor for head circumference
and placental weight.
It is unclear whether ALS affects prenatal growth.23 The
birth weights of ALS/ and ALSþ/ mice are not different
from those of the wild type,14 and most patients with ho-
mozygous or heterozygous ALS gene mutations have normal
birth weights and heights.18,19 Our results, however,
showed that ALS was a positive independent predictor of
birth weight, head circumference, and placental weight.
Compatible with our results is that there is a trend for
patients of short stature with the IGFALS gene mutation to
have a low birth weight, according to the small number of
case reports published on patients whose birth weights
were available. Their mean birth weight is 1.0 standard
deviation score (range: e2.23 to 0.08).24 In human fetal
circulation, ALS umbilical cord blood levels increase
significantly after 25e30 weeks of gestation.20 Our data
further indicated that IGF-I, IGFBP-3, and ALS plasma levels
in the umbilical cord were highly correlated to one another
at term gestation. This suggests that ALS may act welleights.
Male (n Z 45) Female (n Z 53)
39.3 (37.4e41.4) 39.6 (37.1e41.3)
3200 (2348e4038) 3120 (2300e3914)
51.1 (45.0e58.0) 50.3 (46.0e56.0)
34.0 (32.0e36.0) 33.6 (31.0e35.0)
2.41 (2.02e2.97) 2.46 (1.95e3.80)
680 (450e1000) 653 (470e1100)
Table 2 Cord plasma levels of the study hormones.
All births (n Z 98) Male (n Z 45) Female (n Z 53)
ALS (mg/mL) 3.01 (0.29e6.41) 2.78 (0.73e5.94) 3.19 (0.29e6.41)
IGF-I (ng/mL) 91.0 (30.7e190.5) 86.8 (33.9e171.2) 96.4 (41.2e190.1)
IGFBP-3 (ng/mL) 1524.4 (986.7e2182.5) 1467.1 (1054.2e2182.5) 1576.0 (1075.2e2140.3)
Data are presented as means with range in parentheses.
ALS Z acid-labile subunit; IGF-I Z insulin-like growth factor-I; IGFBP-3 Z IGF-binding protein 3.
142 Y.-M. Tseng et albefore birth to prolong IGF-I half-life, thereby affecting
birth size. The differential effect of the IGFALS gene null
mutation on birth weights in humans and mice may reflect
the difference in the timing of the maturation of the IGF
endocrine system.
Of all the predictor variables, only ALS significantly
predicted three of the four parameters associated with
birth size, namely, birth weight, head circumference, and
placental weight, but not birth length. This is compatible
with the observations of a previous study which reportedFigure 1 The birth weights of the neonates that participated
in this study are plotted on nationwide singleton birth-weight
percentile curves for Taiwan.that patients of short stature who have the IGFALS gene
mutation had normal birth lengths.24 In contrast to our
results, Lo et al reported that in a mixed population of 81
preterm and term neonates, ALS umbilical levels were in-
dependent predictors for birth length.21 The difference
may be due to their sample size or the effect of ALS on
different gestational age groups.
The Ponderal index is an indicator of soft-tissue mass
relative to skeletal development.25 In our study, regression
analysis indicated that ALS levels were positive predictors
for birth weights but not birth lengths. The Ponderal index
was calculated as 100 times birth weight in gram divided by
the cube of birth length in centimeter. Therefore, it is
conceivable that ALS levels were not a predictor for the
Ponderal index in regression analysis because of the cubic
effect of birth length. This suggests that the primary in-
fluence of ALS on birth anthropometry is on birth weight.
Our study has some limitations. Hormone measurements
were obtained from term neonates at birth. Therefore, our
data cannot reflect the effect of these hormones on fetal
growth at different gestational ages. In addition, our study
is an association study, not a causeeeffect study, which is
usually a limitation in human studies.
It is known that hormones act through autocrine, para-
crine, or endocrine functions. The autocrine/paracrine IGF
system is generally thought to be of primary importance in
fetal growth.26 Our samples were obtained from cord blood
and can represent at most the endocrine aspect of these
study hormones. Therefore, we could not detect the dif-
ferential effects of ALS, IGF-I, and IGFBP-3 autocrine/Table 3 Correlation coefficients (r) between anthropo-
metric data and the study hormones in cord plasma.
BW BL HC PI PW ALS IGF-I
BL 0.62* d d d d d d
HC 0.63* 0.43* d d d d d
PI 0.35* 0.52* 0.17 d d d d
PW 0.54* 0.29** 0.20 0.24*** d d d
ALS 0.42* 0.19 0.29** 0.23*** 0.37* d d
IGF-I 0.43* 0.17 0.11 0.25*** 0.31** 0.47* d




ALS Z acid-labile subunit; BW Z birth weight; BL Z birth
length; HC Z head circumference; IGF-I Z insulin-like growth
factor-I; IGFBP-3Z IGF-binding protein 3; PIZ Ponderal index;
PW Z placental weight.
Table 4 Multiple linear regression analyses of the study hormones and size at birth.
Covariate b (95% CI) Adjusted r2 (%) p
Birth weight (g) 24.3
ALS (mg/mL) 64.6 (18.5e110.8) <0.01
IGF-I (ng/mL) 3.99 (1.51e6.46) <0.005
IGFBP-3 (ng/mL) 0.12 (0.40 to 0.16) 0.41
Birth length (cm) 2.3
ALS (mg/mL) 0.21 (0.09 to 0.51) 0.164
IGF-I (ng/mL) 0.01 (0.01 to 0.03) 0.221
IGFBP-3 (ng/mL) 0.000 (0.003 to 0.001) 0.298
Head circumference (cm) 6.2
ALS (mg/mL) 0.203 (0.05e0.36) <0.01
IGF-I (ng/mL) 0.002 (0.006 to 0.01) 0.67
IGFBP-3 (ng/mL) 0.000 (0.001 to 0.001) 0.41
Ponderal index (g/cm3) 5.6
ALS (mg/mL) 0.023 (0.018 to 0.06) 0.27
IGF-I (ng/mL) 0.002 (0.000 to 0.004) 0.15
IGFBP-3 (ng/mL) 0.00 (0.00 to 0.00) 0.76
Placental weight (g) 14.6
ALS (mg/mL) 22.8 (3.78e41.86) <0.05
IGF-I (ng/mL) 0.69 (0.36 to 1.74) 0.19
IGFBP-3 (ng/mL) 0.04 (0.07 to 0.16) 0.47
ALS Z acid-labile subunit; CI Z confidence interval; IGF-I Z insulin-like growth factor-I; IGFBP-3 Z IGF-binding protein 3.
Acid-labile subunit and birth size 143paracrine function on fetal growth. Indeed, it has been
reported that, in addition to the liver, local ALS gene
expression is also found in developing bone, kidney,
thymus, lactating mammary gland, and lung tissue.27,28
Moreover, ALS may have its own functions independent of
the IGF system. Indeed, despite similar degrees of reduc-
tion in circulating IGF-I, liver-specific IGF-I knockout mice
and ALS knockout mice have different insulin sensitivity,
growth hormone levels, and fat metabolism.29e31 There-
fore, the differential roles of ALS and IGF-I on fetal growth
warrant further investigation.
In conclusion, we have found that ALS, in addition to
IGF-I, is a significant positive predictor for birth weight and
head circumference. The endocrine IGF system may start to
mature during the second or third trimester, when ALS
excretion increases and forms ternary complexes with IGF-I
and IGFBP-3 to prolong the action of IGF-I and affect fetal
growth.Conflicts of Interest
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